Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary biliary cirrhosis
|
667 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||
Colorectal Carcinoma
|
1962 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.030 | 1.000 | 3 | 2009 | 2014 | ||||
Coronary Artery Disease
|
1577 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.030 | 1.000 | 3 | 2011 | 2013 | ||||
Nasopharyngeal carcinoma
|
320 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.030 | 1.000 | 3 | 2009 | 2014 | ||||
Endometriosis
|
274 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.020 | 0.500 | 2 | 2010 | 2018 | ||||
Malignant Neoplasms
|
1641 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Primary malignant neoplasm
|
1374 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Renal Cell Carcinoma
|
288 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.020 | 0.500 | 2 | 2016 | 2019 | ||||
Childhood Osteosarcoma
|
151 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1 | 2019 | 2019 | |||||
Coronary Arteriosclerosis
|
440 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Coronary heart disease
|
1178 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hepatitis B, Chronic
|
84 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Liver carcinoma
|
942 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Malignant neoplasm of prostate
|
1082 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant neoplasm of stomach
|
615 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Multiple Sclerosis
|
1022 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Osteoarthritis, Knee
|
150 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Osteoporosis
|
182 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Osteosarcoma
|
178 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Osteosarcoma of bone
|
151 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Pancreatitis
|
80 | 0.653 | 0.600 | 15 | 81305928 | missense variant | T/G | snv | 9.6E-02 | 0.12 | 0.010 | 1.000 | 1 | 2017 | 2017 |